GR3032212T3 - Melanoma-inhibiting protein - Google Patents

Melanoma-inhibiting protein

Info

Publication number
GR3032212T3
GR3032212T3 GR990403299T GR990403299T GR3032212T3 GR 3032212 T3 GR3032212 T3 GR 3032212T3 GR 990403299 T GR990403299 T GR 990403299T GR 990403299 T GR990403299 T GR 990403299T GR 3032212 T3 GR3032212 T3 GR 3032212T3
Authority
GR
Greece
Prior art keywords
iib
iia
protein
melanoma
htz
Prior art date
Application number
GR990403299T
Other languages
English (en)
Inventor
Ulrich Bogdahn
Reinhard Buettner
Brigitte Kaluza
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of GR3032212T3 publication Critical patent/GR3032212T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GR990403299T 1993-07-20 1999-12-22 Melanoma-inhibiting protein GR3032212T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4324247 1993-07-20
PCT/EP1994/002369 WO1995003328A2 (de) 1993-07-20 1994-07-19 Melanom-inhibierendes protein

Publications (1)

Publication Number Publication Date
GR3032212T3 true GR3032212T3 (en) 2000-04-27

Family

ID=6493222

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990403299T GR3032212T3 (en) 1993-07-20 1999-12-22 Melanoma-inhibiting protein

Country Status (14)

Country Link
US (1) US5770366A (el)
EP (2) EP0947583A3 (el)
JP (1) JP3435163B2 (el)
CN (1) CN1056617C (el)
AT (1) ATE185152T1 (el)
AU (1) AU7531294A (el)
CA (1) CA2167693C (el)
DE (2) DE4425481A1 (el)
DK (1) DK0710248T3 (el)
ES (1) ES2139751T3 (el)
GR (1) GR3032212T3 (el)
IL (2) IL110385A (el)
WO (1) WO1995003328A2 (el)
ZA (1) ZA945278B (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653358A1 (de) * 1996-12-20 1998-06-25 Boehringer Mannheim Gmbh Immunoassay zum Nachweis von MIA
US6653445B1 (en) * 1997-01-21 2003-11-25 Human Genome Sciences, Inc. Human CCV polypeptides
US6492144B1 (en) * 1997-05-30 2002-12-10 Diagen Corporation Methods for detection of nucleic acid sequences in urine
USRE39920E1 (en) 1997-05-30 2007-11-13 Xenomics, Inc. Methods for detection of nucleic acid sequences in urine
EP0945507A1 (de) * 1998-03-27 1999-09-29 Boehringer Mannheim Gmbh Tumorspezifische Expressionskontrollregion und deren Verwendung
US20020103360A1 (en) * 1998-09-01 2002-08-01 Yang Pan Novel protein related to melanoma-inhibiting protein and uses thereof
US20030072767A1 (en) * 1998-09-30 2003-04-17 Alexander Gaiger Compositions and methods for WT1 specific immunotherapy
EP1025871A1 (en) * 1999-01-28 2000-08-09 F. Hoffmann-La Roche Ag Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
US6713293B1 (en) * 1999-02-08 2004-03-30 Friedrich Grummt Encapsulated cells containing an amplified expression vector as a drug delivery device
US6797483B1 (en) 1999-06-30 2004-09-28 Takeda Chemical Industries, Ltd. Polypeptide and DNA thereof
AU2001232967A1 (en) * 2000-01-25 2001-08-07 Hyseq, Inc. Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
EP1133994A1 (en) * 2000-03-11 2001-09-19 Biognostik Gesellschaft für biomolekulare Diagnostik mbH A method for reversing the immunosuppressive effects of the Melanoma Inhibitory Activity "MIA"
US20030091583A1 (en) * 2000-03-23 2003-05-15 Hubert Nelissen Robert Louis Use of mia in immunotheraphy
US6613534B2 (en) 2001-03-20 2003-09-02 Wake Forest University Health Sciences MAP-2 as a determinant of metastatic potential
US20100212037A1 (en) * 2002-10-16 2010-08-19 Anja Katrin Bosserhoff Mia-2 protein
US8288087B2 (en) * 2006-07-28 2012-10-16 Novartis Ag Use of melanoma inhibitory activity (MIA) protein as an early indicator for therapeutic response in melanoma
ES2415245T5 (es) * 2007-08-22 2016-12-23 Trovagene, Inc. Métodos de uso de miARN para la detección de muerte celular in vivo
RU2588658C2 (ru) 2010-04-27 2016-07-10 ЭсСиАйЭл Текнолоджи ГмбХ Стабильные водные композиции белка mia/cd-rap
MX2013001536A (es) * 2010-08-30 2013-03-18 Hoffmann La Roche Construccion de expresion procariotica.
ITRM20110134A1 (it) * 2011-03-22 2012-09-23 Matteo Bordignon Inibitori di mia (attività inibitoria melanoma) per identificare, prevenire e curare la vitiligine

Also Published As

Publication number Publication date
IL154248A (en) 2008-08-07
IL110385A0 (en) 1994-10-21
EP0947583A3 (de) 2000-05-03
CA2167693A1 (en) 1995-02-02
EP0947583A2 (de) 1999-10-06
WO1995003328A3 (de) 1995-03-16
DE59408791D1 (de) 1999-11-04
ATE185152T1 (de) 1999-10-15
CA2167693C (en) 2007-01-30
US5770366A (en) 1998-06-23
CN1056617C (zh) 2000-09-20
CN1133049A (zh) 1996-10-09
WO1995003328A2 (de) 1995-02-02
ZA945278B (en) 1996-01-19
EP0710248A1 (de) 1996-05-08
AU7531294A (en) 1995-02-20
DE4425481A1 (de) 1995-03-02
ES2139751T3 (es) 2000-02-16
IL110385A (en) 2003-12-10
JP3435163B2 (ja) 2003-08-11
DK0710248T3 (da) 2000-04-10
EP0710248B1 (de) 1999-09-29
IL154248A0 (en) 2003-09-17
JPH09500531A (ja) 1997-01-21

Similar Documents

Publication Publication Date Title
GR3032212T3 (en) Melanoma-inhibiting protein
ZA200005843B (en) New nucleotide sequences which code for the pck gene.
HK1007435A1 (en) Protein having cytokin type activity recombinant dna coding for this protein transformed cells and microorganisms
AU2795292A (en) Synthetic dna sequence having enhanced insecticidal activity in maize
HK1004150A1 (en) Calcium free subtilisin mutants.
CA2327266A1 (en) Pesticidal toxins and nucleotide sequences which encode these toxins
CA2204257A1 (en) Tripeptidyl aminopeptidase
CA2102702A1 (en) Vitamin K-Dependent Carboxylase
CA2252493A1 (en) .beta.-galactoside - .alpha. 2,6-sialyltransferase gene
EP0479071A3 (en) Polypeptide
IL141869A0 (en) Mammalian transforming growth factor beta-9 (ztgfss9)
CA2191222C (en) Dna encoding the bacillus licheniformis pwd-1 keratinase
AU2898995A (en) Dna coding for phosphoenolpyruvate carboxykinase, recombinant vector containing the same, and transgenic plant
AU7949991A (en) Cloned n-methylhydantoinase
CA2301902A1 (en) Novel extracellular serine protease
CA2155332A1 (en) Polypeptide having cold-stable pyruvate, orthophosphate dikinase activity, dna encoding the same and recombinant vector and transformed plants containing the dna
CA2144601A1 (en) Recombinant type ii collagenase from clostridium histolyticum and its use for isolating cells and groups of cells
ES2179760A1 (es) Genes codificantes de beta-agarasas y su utilizacion para producir enzimas de biodegradacion de agares.
AU5637298A (en) Novel cytochrome P450 gene
ES8700694A1 (es) Un procedimiento para producir un polipeptido de interferon hibrido antivirico y antiproliferante
EP0477791A3 (en) Polypeptide
ATE398681T1 (de) Nukleotidsequenzen die für das mene-gen kodieren
MX9605473A (es) Polipeptido hk2 recombinante.
ES2023538A6 (es) Procedimiento de obtencion y purificacion del fragmento carboxilo-terminal de la dna polimerasa i de streptococcus pneumoniae